BAQSIMI 
Procedural steps taken and scientific information after the authorisation 
Application 
Scope 
number 
Opinion/ 
Commission 
Product 
Summary 
Notification
Decision 
Information 
1 issued on 
Issued 2 / 
affected 3  
amended 
on 
N/0007 
Minor change in labelling or package leaflet not 
18/06/2021 
Labelling 
connected with the SPC  (Art. 61.3 Notification) 
PSUSA/10826
Periodic Safety Update EU Single assessment - 
11/02/2021 
n/a 
PRAC  Recommendation - maintenance 
/202007 
glucagon (for centrally authorised product only) 
IA/0006/G 
This was an application for a group of variations. 
02/02/2021 
n/a 
1 Notifications are issued for type I  variations and Article 61(3) notifications (unless part of a group including a type II  variation or extension application or a worksharing application). Opinions 
are issued for all other procedures. 
2 A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II,  labelling, package leaflet). The 
CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures. 
3 SmPC  (Summary  of Product Characteristics), Annex II,  Labelling, PL (Package Leaflet). 
Official address  Domenico Scarlattilaan 6  ●  1083 HS Amsterdam  ●  The Netherlands 
Address for visits and deliveries  Refer to www.ema.europa.eu/how-to-find-us  
Send us a question  Go to www.ema.europa.eu/contact   Telephone +31 (0)88 781 6000 
An agency of the European  Union 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B.II.d.2.a  - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.II.c.2.a  - Change in test procedure for an excipient 
- Minor changes to an approved test procedure 
B.II.d.2.a  - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.II.d.2.a  - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.II.d.2.a  - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.II.c.2.a  - Change in test procedure for an excipient 
- Minor changes to an approved test procedure 
B.II.d.2.a  - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.II.d.2.a  - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.II.d.2.a  - Change in test procedure for the finished 
product - Minor changes to an approved test 
procedure 
B.II.c.2.a  - Change in test procedure for an excipient 
- Minor changes to an approved test procedure 
B.II.c.2.a  - Change in test procedure for an excipient 
- Minor changes to an approved test procedure 
B.II.c.2.a  - Change in test procedure for an excipient 
- Minor changes to an approved test procedure 
Page 2/3 
 
 
 
B.I.a.2.a  - Changes in the manufacturing process of 
the AS - Minor change in the manufacturing process 
of the AS 
PSUSA/10826
Periodic Safety Update EU Single assessment - 
03/09/2020 
n/a 
PRAC  Recommendation - maintenance 
/202001 
glucagon (for centrally authorised product only) 
IAIN/0004 
B.II.b.2.c.1  - Change to importer, batch release 
06/07/2020 
n/a 
arrangements and quality control testing of the FP - 
Replacement or addition of a manufacturer 
responsible for importation and/or batch release - 
Not including batch control/testing 
IA/0002 
B.II.b.2.a  - Change to importer, batch release 
17/04/2020 
n/a 
arrangements and quality control testing of the FP - 
Replacement/addition of a site where batch 
control/testing takes place 
Page 3/3 
 
 
 
 
 
 
 
 
 
 
 
 
